These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 314017)

  • 21. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rh-antibodies in women receiving preventive treatment against Rh-immunization. Experiences after 2 years preventive program].
    Orjasaeter H
    Tidsskr Nor Laegeforen; 1972 Dec; 92(35):2412-4. PubMed ID: 4120943
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemolytic disease of the newborn due to RH-Hr incompatibility in Japan, with reference to the study of its mechanism of development].
    Jimi H
    Igaku Kenkyu; 1967 Nov; 37(6):644-61. PubMed ID: 5627049
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hemolytic disease of the newborn infant. Occurrence and therapeutic results].
    Aichner R
    Wien Med Wochenschr; 1970 Jul; 120(27):494-7. PubMed ID: 5314307
    [No Abstract]   [Full Text] [Related]  

  • 25. [Obtaining blood group test serums and initial plasma for the preparation of anti D-immunologlobulin for prevention of hemolytic disease of newborn by artificial immunization].
    Pilgrim G; Wicht U
    Z Gesamte Inn Med; 1971 Jan; 26(1):26-30. PubMed ID: 4997869
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of post-partum Rh-factor isoimmunization (experience of the Hospital 1st Gynecological-Obstetrical of the Mexican Institute of Social Security)].
    Cepeda AG; Sentíes L; Fiorelli FE; Garcete JA
    Ginecol Obstet Mex; 1975 Feb; 37(220):83-91. PubMed ID: 804430
    [No Abstract]   [Full Text] [Related]  

  • 27. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
    Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of gamma globulin anti D prophylaxis on the reduction of anti D antibodies and the relative increase of other incompatibilities].
    Krauss A; Berge H; Gerl D; Klug C; Rahm C
    Z Arztl Fortbild (Jena); 1980 Mar; 74(5):215-7. PubMed ID: 6158184
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunization of animals with anti-D immunoglobulin used for prophylaxis of hemolytic disease of newborns. 3. Antiglobulin immune antibodies obtained by immunizing rabbits with IgG anti-D immunoglobulin and their pattern in immunodiffusion and immunoelectrophoresis.
    Polak S; Marzec Z; Skorczyński M; Styblińska M
    Arch Immunol Ther Exp (Warsz); 1972; 20(5):687-92. PubMed ID: 4632604
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of hemolytic disease in newborns caused by antiagglutinins E (RH)].
    Argirov A; Mikhova M
    Vopr Okhr Materin Det; 1968 Oct; 13(10):71-2. PubMed ID: 4976398
    [No Abstract]   [Full Text] [Related]  

  • 31. [The Kleihauer test and directed prevention of hemolytic disease of the newborn due to materno-fetal Rh-factor isoimmunization. Preventive note].
    De Luca P; Adinolfi G; Corbo M
    Minerva Ginecol; 1980 Dec; 32(12):1179-81. PubMed ID: 6793940
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of fetal erythroblastosis in Banská Bystrica].
    Calkovská Z
    Cesk Pediatr; 1972 Nov; 27(11):563. PubMed ID: 4539057
    [No Abstract]   [Full Text] [Related]  

  • 33. [Development of immunologic prevention of the hemolytic disease of newborns using anti-D immunoglobulin in the German Democratic Republic].
    Schubert W
    Dtsch Gesundheitsw; 1969 Dec; 24(50):2395-7. PubMed ID: 4193270
    [No Abstract]   [Full Text] [Related]  

  • 34. Rho (d) immune globulin (human).
    Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of Rh-immunization with the Rho(D)-immunoglobulin G (RhoGAM)].
    Robertson JG
    Med Welt; 1970 Nov; 46():1991-5. PubMed ID: 4997857
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic Rh disease in Vizcay (current preventive possibilities)].
    Goti JL
    Rev Clin Esp; 1968 Apr; 109(1):37-46. PubMed ID: 4188597
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiology of Rh hemolytic disease of the newborn, United States, 1960-1979.
    Adams MM; Gustafson J
    Prog Clin Biol Res; 1981; 70():213-7. PubMed ID: 6273934
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of Rh-isoimmunization in connection with spontaneous abortion and interruption of pregnancy].
    Kiss D; Szöke B
    Zentralbl Gynakol; 1974 Mar; 96(13):398-401. PubMed ID: 4208562
    [No Abstract]   [Full Text] [Related]  

  • 39. The prevention of Rh-haemolytic disease.
    Clarke CA
    Sci Basis Med Annu Rev; 1968; ():168-85. PubMed ID: 4970016
    [No Abstract]   [Full Text] [Related]  

  • 40. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.